Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

4.25
-0.3700-8.01%
Post-market: 4.250.00000.00%16:05 EDT
Volume:468.96K
Turnover:2.04M
Market Cap:273.09M
PE:-4.20
High:4.59
Open:4.54
Low:4.19
Close:4.62
Loading ...

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer

THOMSON REUTERS
·
10 Nov 2024

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer

GlobeNewswire
·
10 Nov 2024

Corvus Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire
·
06 Nov 2024

Corvus Pharmaceuticals options imply 12.0% move in share price post-earnings

TIPRANKS
·
06 Nov 2024

Corvus Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
02 Nov 2024

Corvus Pharmaceuticals Shares Rise After Mizuho Upgrade

MT Newswires Live
·
23 Oct 2024

Corvus Pharmaceuticals Shares up 3.6% After Mizuho Raises to Outperform From Neutral

THOMSON REUTERS
·
22 Oct 2024

BUZZ-Corvus Pharmaceuticals jumps after Mizuho upgrades to 'outperform'

Reuters
·
22 Oct 2024

Mizuho Upgrades Corvus Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $12 From $3.50

MT Newswires Live
·
22 Oct 2024

Corvus Pharmaceuticals upgraded to Outperform from Neutral at Mizuho

TIPRANKS
·
22 Oct 2024

Corvus Pharmaceuticals Inc : Mizuho Raises to Outperform From Neutral

THOMSON REUTERS
·
22 Oct 2024

Insiders of Corvus Pharmaceuticals Getting Good Value On Their US$1.03m Investment

Simply Wall St.
·
17 Oct 2024